Loading…

Prognostic and Predictive Value of the 21-Gene Recurrence Score Assay in a Randomized Trial of Chemotherapy for Postmenopausal, Node-Positive, Estrogen Receptor-Positive Breast Cancer

Saved in:
Bibliographic Details
Published in:The lancet oncology 2009-12, Vol.11 (1), p.55-65
Main Authors: Albain, Kathy S., Barlow, William E., Shak, Steven, Hortobagyi, Gabriel N., Livingston, Robert B., Yeh, I-Tien, Ravdin, Peter, Bugarini, Roberto, Baehner, Frederick L., Davidson, Nancy E., Sledge, George W., Winer, Eric P., Hudis, Clifford, Ingle, James N., Perez, Edith A., Pritchard, Kathleen I., Shepherd, Lois, Gralow, Julie R., Yoshizawa, Carl, Allred, D. Craig, Osborne, C. Kent, Hayes, Daniel F.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 65
container_issue 1
container_start_page 55
container_title The lancet oncology
container_volume 11
creator Albain, Kathy S.
Barlow, William E.
Shak, Steven
Hortobagyi, Gabriel N.
Livingston, Robert B.
Yeh, I-Tien
Ravdin, Peter
Bugarini, Roberto
Baehner, Frederick L.
Davidson, Nancy E.
Sledge, George W.
Winer, Eric P.
Hudis, Clifford
Ingle, James N.
Perez, Edith A.
Pritchard, Kathleen I.
Shepherd, Lois
Gralow, Julie R.
Yoshizawa, Carl
Allred, D. Craig
Osborne, C. Kent
Hayes, Daniel F.
description
doi_str_mv 10.1016/S1470-2045(09)70314-6
format article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3058239</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_3058239</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_30582393</originalsourceid><addsrcrecordid>eNqljs1KA0EQhAdRTPx5BKGPClmd2Z9schE0RD1JSILXpd3tJCO7M0vPbCC-mK_nREXw7Kmbqu76SogLJa-VVMObhUpzGcUyzS7l-CqXiUqj4YHoBzmNsnQ0Ovzav0964sS5NylVrmR2LHqxlDJTedoXHzO2a2Od1yWgqWDGVOnS6y3BC9YdgV2B3xDEKnokQzCnsmMmUxIsSssEd87hDrQBhHkIsI1-pwqWrLHe_0421NgQwNjuYGUZZoHVkLEtdg7rATzbiqIg6j1zAFPnQyEyexC13vKvB_dM6DxMMMD5TBytsHZ0_jNPxe3DdDl5itrutaGqJOMZ66Jl3SDvCou6-OsYvSnWdlskMhvFyTj5d8AnCO6EEA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prognostic and Predictive Value of the 21-Gene Recurrence Score Assay in a Randomized Trial of Chemotherapy for Postmenopausal, Node-Positive, Estrogen Receptor-Positive Breast Cancer</title><source>ScienceDirect Journals</source><creator>Albain, Kathy S. ; Barlow, William E. ; Shak, Steven ; Hortobagyi, Gabriel N. ; Livingston, Robert B. ; Yeh, I-Tien ; Ravdin, Peter ; Bugarini, Roberto ; Baehner, Frederick L. ; Davidson, Nancy E. ; Sledge, George W. ; Winer, Eric P. ; Hudis, Clifford ; Ingle, James N. ; Perez, Edith A. ; Pritchard, Kathleen I. ; Shepherd, Lois ; Gralow, Julie R. ; Yoshizawa, Carl ; Allred, D. Craig ; Osborne, C. Kent ; Hayes, Daniel F.</creator><creatorcontrib>Albain, Kathy S. ; Barlow, William E. ; Shak, Steven ; Hortobagyi, Gabriel N. ; Livingston, Robert B. ; Yeh, I-Tien ; Ravdin, Peter ; Bugarini, Roberto ; Baehner, Frederick L. ; Davidson, Nancy E. ; Sledge, George W. ; Winer, Eric P. ; Hudis, Clifford ; Ingle, James N. ; Perez, Edith A. ; Pritchard, Kathleen I. ; Shepherd, Lois ; Gralow, Julie R. ; Yoshizawa, Carl ; Allred, D. Craig ; Osborne, C. Kent ; Hayes, Daniel F.</creatorcontrib><identifier>ISSN: 1470-2045</identifier><identifier>EISSN: 1474-5488</identifier><identifier>DOI: 10.1016/S1470-2045(09)70314-6</identifier><identifier>PMID: 20005174</identifier><language>eng</language><ispartof>The lancet oncology, 2009-12, Vol.11 (1), p.55-65</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids></links><search><creatorcontrib>Albain, Kathy S.</creatorcontrib><creatorcontrib>Barlow, William E.</creatorcontrib><creatorcontrib>Shak, Steven</creatorcontrib><creatorcontrib>Hortobagyi, Gabriel N.</creatorcontrib><creatorcontrib>Livingston, Robert B.</creatorcontrib><creatorcontrib>Yeh, I-Tien</creatorcontrib><creatorcontrib>Ravdin, Peter</creatorcontrib><creatorcontrib>Bugarini, Roberto</creatorcontrib><creatorcontrib>Baehner, Frederick L.</creatorcontrib><creatorcontrib>Davidson, Nancy E.</creatorcontrib><creatorcontrib>Sledge, George W.</creatorcontrib><creatorcontrib>Winer, Eric P.</creatorcontrib><creatorcontrib>Hudis, Clifford</creatorcontrib><creatorcontrib>Ingle, James N.</creatorcontrib><creatorcontrib>Perez, Edith A.</creatorcontrib><creatorcontrib>Pritchard, Kathleen I.</creatorcontrib><creatorcontrib>Shepherd, Lois</creatorcontrib><creatorcontrib>Gralow, Julie R.</creatorcontrib><creatorcontrib>Yoshizawa, Carl</creatorcontrib><creatorcontrib>Allred, D. Craig</creatorcontrib><creatorcontrib>Osborne, C. Kent</creatorcontrib><creatorcontrib>Hayes, Daniel F.</creatorcontrib><title>Prognostic and Predictive Value of the 21-Gene Recurrence Score Assay in a Randomized Trial of Chemotherapy for Postmenopausal, Node-Positive, Estrogen Receptor-Positive Breast Cancer</title><title>The lancet oncology</title><issn>1470-2045</issn><issn>1474-5488</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqljs1KA0EQhAdRTPx5BKGPClmd2Z9schE0RD1JSILXpd3tJCO7M0vPbCC-mK_nREXw7Kmbqu76SogLJa-VVMObhUpzGcUyzS7l-CqXiUqj4YHoBzmNsnQ0Ovzav0964sS5NylVrmR2LHqxlDJTedoXHzO2a2Od1yWgqWDGVOnS6y3BC9YdgV2B3xDEKnokQzCnsmMmUxIsSssEd87hDrQBhHkIsI1-pwqWrLHe_0421NgQwNjuYGUZZoHVkLEtdg7rATzbiqIg6j1zAFPnQyEyexC13vKvB_dM6DxMMMD5TBytsHZ0_jNPxe3DdDl5itrutaGqJOMZ66Jl3SDvCou6-OsYvSnWdlskMhvFyTj5d8AnCO6EEA</recordid><startdate>20091210</startdate><enddate>20091210</enddate><creator>Albain, Kathy S.</creator><creator>Barlow, William E.</creator><creator>Shak, Steven</creator><creator>Hortobagyi, Gabriel N.</creator><creator>Livingston, Robert B.</creator><creator>Yeh, I-Tien</creator><creator>Ravdin, Peter</creator><creator>Bugarini, Roberto</creator><creator>Baehner, Frederick L.</creator><creator>Davidson, Nancy E.</creator><creator>Sledge, George W.</creator><creator>Winer, Eric P.</creator><creator>Hudis, Clifford</creator><creator>Ingle, James N.</creator><creator>Perez, Edith A.</creator><creator>Pritchard, Kathleen I.</creator><creator>Shepherd, Lois</creator><creator>Gralow, Julie R.</creator><creator>Yoshizawa, Carl</creator><creator>Allred, D. Craig</creator><creator>Osborne, C. Kent</creator><creator>Hayes, Daniel F.</creator><scope>5PM</scope></search><sort><creationdate>20091210</creationdate><title>Prognostic and Predictive Value of the 21-Gene Recurrence Score Assay in a Randomized Trial of Chemotherapy for Postmenopausal, Node-Positive, Estrogen Receptor-Positive Breast Cancer</title><author>Albain, Kathy S. ; Barlow, William E. ; Shak, Steven ; Hortobagyi, Gabriel N. ; Livingston, Robert B. ; Yeh, I-Tien ; Ravdin, Peter ; Bugarini, Roberto ; Baehner, Frederick L. ; Davidson, Nancy E. ; Sledge, George W. ; Winer, Eric P. ; Hudis, Clifford ; Ingle, James N. ; Perez, Edith A. ; Pritchard, Kathleen I. ; Shepherd, Lois ; Gralow, Julie R. ; Yoshizawa, Carl ; Allred, D. Craig ; Osborne, C. Kent ; Hayes, Daniel F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_30582393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Albain, Kathy S.</creatorcontrib><creatorcontrib>Barlow, William E.</creatorcontrib><creatorcontrib>Shak, Steven</creatorcontrib><creatorcontrib>Hortobagyi, Gabriel N.</creatorcontrib><creatorcontrib>Livingston, Robert B.</creatorcontrib><creatorcontrib>Yeh, I-Tien</creatorcontrib><creatorcontrib>Ravdin, Peter</creatorcontrib><creatorcontrib>Bugarini, Roberto</creatorcontrib><creatorcontrib>Baehner, Frederick L.</creatorcontrib><creatorcontrib>Davidson, Nancy E.</creatorcontrib><creatorcontrib>Sledge, George W.</creatorcontrib><creatorcontrib>Winer, Eric P.</creatorcontrib><creatorcontrib>Hudis, Clifford</creatorcontrib><creatorcontrib>Ingle, James N.</creatorcontrib><creatorcontrib>Perez, Edith A.</creatorcontrib><creatorcontrib>Pritchard, Kathleen I.</creatorcontrib><creatorcontrib>Shepherd, Lois</creatorcontrib><creatorcontrib>Gralow, Julie R.</creatorcontrib><creatorcontrib>Yoshizawa, Carl</creatorcontrib><creatorcontrib>Allred, D. Craig</creatorcontrib><creatorcontrib>Osborne, C. Kent</creatorcontrib><creatorcontrib>Hayes, Daniel F.</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>The lancet oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Albain, Kathy S.</au><au>Barlow, William E.</au><au>Shak, Steven</au><au>Hortobagyi, Gabriel N.</au><au>Livingston, Robert B.</au><au>Yeh, I-Tien</au><au>Ravdin, Peter</au><au>Bugarini, Roberto</au><au>Baehner, Frederick L.</au><au>Davidson, Nancy E.</au><au>Sledge, George W.</au><au>Winer, Eric P.</au><au>Hudis, Clifford</au><au>Ingle, James N.</au><au>Perez, Edith A.</au><au>Pritchard, Kathleen I.</au><au>Shepherd, Lois</au><au>Gralow, Julie R.</au><au>Yoshizawa, Carl</au><au>Allred, D. Craig</au><au>Osborne, C. Kent</au><au>Hayes, Daniel F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic and Predictive Value of the 21-Gene Recurrence Score Assay in a Randomized Trial of Chemotherapy for Postmenopausal, Node-Positive, Estrogen Receptor-Positive Breast Cancer</atitle><jtitle>The lancet oncology</jtitle><date>2009-12-10</date><risdate>2009</risdate><volume>11</volume><issue>1</issue><spage>55</spage><epage>65</epage><pages>55-65</pages><issn>1470-2045</issn><eissn>1474-5488</eissn><pmid>20005174</pmid><doi>10.1016/S1470-2045(09)70314-6</doi></addata></record>
fulltext fulltext
identifier ISSN: 1470-2045
ispartof The lancet oncology, 2009-12, Vol.11 (1), p.55-65
issn 1470-2045
1474-5488
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3058239
source ScienceDirect Journals
title Prognostic and Predictive Value of the 21-Gene Recurrence Score Assay in a Randomized Trial of Chemotherapy for Postmenopausal, Node-Positive, Estrogen Receptor-Positive Breast Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T19%3A55%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20and%20Predictive%20Value%20of%20the%2021-Gene%20Recurrence%20Score%20Assay%20in%20a%20Randomized%20Trial%20of%20Chemotherapy%20for%20Postmenopausal,%20Node-Positive,%20Estrogen%20Receptor-Positive%20Breast%20Cancer&rft.jtitle=The%20lancet%20oncology&rft.au=Albain,%20Kathy%20S.&rft.date=2009-12-10&rft.volume=11&rft.issue=1&rft.spage=55&rft.epage=65&rft.pages=55-65&rft.issn=1470-2045&rft.eissn=1474-5488&rft_id=info:doi/10.1016/S1470-2045(09)70314-6&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_3058239%3C/pubmedcentral%3E%3Cgrp_id%3Ecdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_30582393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/20005174&rfr_iscdi=true